Video supervised treatment of patients with pulmonary tuberculosis in a health care center in Lima. Pilot study
DOI:
https://doi.org/10.20453/rmh.v33i1.4163Keywords:
Tuberculosis, telemedicine, therapeutics, PeruAbstract
Objective: To report the characteristics of the implementation process of the video supervised treatment (VST) of patients with pulmonary tuberculosis in a first level health care center of the Social Security in Peru. Methods: An observational study was carried-out including patients enrolled from 18/09/2018 to 24/09/2019. Eight out of nine patients completed the VST, one patient was transferred to other institution before finishing treatment. One nurse trained at Partners in Health arranged the 727 video calls. Results: adherence to treatment was 100%. Conclusions: VST may be a useful alternative for patients with drug sensitive tuberculosis.
References
World Health Organization. Global tuberculosisreport 2019. Ginebra: World Health Organization;2020. (Citado el 15 de marzo del 2021). Disponibleen: https://apps.who.int/iris/handle/10665/329368
Ministerio de Salud del Perú. Norma Técnica deSalud para la Atención Integral de las PersonasAfectadas por Tuberculosis. Lima: Ministerio deSalud del Perú; 2018. (Citado el 15 de marzo del2021). Disponible en: http://www.tuberculosis.minsa.gob.pe/portaldpctb/recursos/20190404114640.PDF3.IETSI-ESSALUD. Eficacia y seguridad del uso delesquema de dosis fijas combinadas (fase inicial y fasede continuación) en comparación con suspresentaciones por separado (tabletas sueltas),para el tratamiento de tuberculosis pulmonar sensibleal tratamiento en adultos. Lima:
IETSI-ESSALUD;2019. (Citado el 15 de marzo del 2021). Disponibleen: http://www.essalud.gob.pe/ietsi/pdfs/directivas/DICT_REC_001_SDEPFYOTS_2019.pdf
Anduaga A, Maticorena-Quevedo J, Beas R, et al.Factores de riesgo para el abandono del tratamiento de tuberculosis pulmonar sensible en unestablecimiento de salud de atención primaria,Lima, Perú. AMP. 2016; 33(1):21-28. (Citado el15 de marzo del 2021). Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1728-59172016000100005&lng=es&nrm=iso&tlng=es
Culqui DR, Grijalva CG, Del S, Reategui R, CajoJM, Suárez LA. Factores pronósticos del abandono del tratamiento antituberculoso en una regiónendémica del Perú. Rev Panam Salud Publica/PanAm J Public Health. 2005; 18(1): 14-20. (Citado el 15de marzo del 2021). Disponible en: https://scielosp.org/article/rpsp/2005.v18n1/14-20/
Culqui D, Munayco E, Grijalva C, et al. Factoresasociados al abandono de tratamiento antituberculosoconvencional en Perú. Arch Bronconeumol.2012;48(5):150–5. doi: 10.1016/j.arbres.2011.12.008
Bagchi S, Ambe G, Sathiakumar N. Determinants ofpoor adherence to anti-tuberculosis treatment inMumbai, India. Int J Prev Med. 2010;1(4):223–32.(Citado el 15 de marzo del 2021). Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075517/
World Health Organization. Digital health for theEnd TB Strategy - an agenda for action. Ginebra:World Health Organization; 2015. (Citado el 15de marzo del 2021). Disponible en: https://www.who.int/tb/areas-of-work/digital-health/Digital_health_EndTBstrategy.pdf?ua=1
Hoffman JA, Cunningham JR, Suleh AJ, et al. MobileDirect Observation Treatment for TuberculosisPatients. A Technical Feasibility Pilot UsingMobile Phones in Nairobi, Kenya. Am J Prev Med].2010;39(1):78–80. doi: 10.1016/j.amepre.2010.02.018
Nguyen TA, Pham MT, Nguyen TL, et al. VideoDirectly Observed Therapy to support adherencewith treatment for tuberculosis in Vietnam: Aprospective cohort study. Int J Infect Dis. 2017;65:85–9. doi: 10.1016/j.ijid.2017.09.029.
Krueger K, Ruby D, Cooley P, et al. Videophoneutilization as an alternative to directly observed therapy for tuberculosis. Int J Tuberc Lung Dis.2010;14(6):779–81. (Citado el 15 de marzo del2021). Disponible en: https://pubmed.ncbi.nlm.nih.gov/20487619/
Chuck C, Robinson E, Macaraig M, Alexander M,Burzynski J. Enhancing management of tuberculosistreatment with video directly observed therapy inNew York City. Int J Tuberc Lung Dis.2016;20(5):588–93. doi: 10.5588/ijtld.15.0738
Garfein RS, Doshi RP. Synchronous and asynchronous video observed therapy (VOT) for tuberculosistreatment adherence monitoring and support. J ClinTuberc Other Mycobact Dis. 2019; 17:100098.Published 2019 Apr 1. doi:10.1016/j.jctube.2019.100098
Garfein RS, Collins K, Muñoz F, et al. Feasibilityof tuberculosis treatment monitoring by videodirectly observed therapy: a binational pilot study.IntJ Tuberc Lung Dis. 2015;19(9):1057-1064. doi:10.5588/ijtld.14.0923
Nsengiyumva NP, Mappin-Kasirer B, Oxlade O, et al.Evaluating the potential costs and impact ofdigital health technologies for tuberculosis treatmentsupport.Eur Respir J. 2018;52(5):1801363. Published2018 Nov 1. doi:10.1183/13993003.01363-2018
Olano-Soler H, Thomas D, Joglar O, et al. Notesfrom the Field: Use of Asynchronous Video DirectlyObserved Therapy for Treatment of Tuberculosisand Latent Tuberculosis Infection in a Long-Term–Care Facility ― Puerto Rico, 2016–2017. MMWRMorb Mortal Wkly Rep 2017; 66:1386–1387. DOI:10.15585/mmwr.mm6650a5
Downloads
Published
How to Cite
Issue
Section
License
Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.
